A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Candesartan/Amlodipine
combined or alone and select better dose of CKD-330 in essential hypertension patients.